Cargando…

The role of pharmacogenetics in the treatment of major depressive disorder: a critical review

Pharmacological therapy represents one of the essential approaches to treatment of Major Depressive Disorder (MDD). However, currently available antidepressant medications show high rates of first-level treatment non-response, and several attempts are often required to find an effective molecule for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barlati, Stefano, Minelli, Alessandra, Nibbio, Gabriele, Bertoni, Lorenzo, Necchini, Nicola, Paolini, Stefano, Muscarella, Alessia, Ubertino, Ughetta Bosco, Calzavara-Pinton, Irene, Vita, Antonio, Gennarelli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667493/ https://www.ncbi.nlm.nih.gov/pubmed/38025425 http://dx.doi.org/10.3389/fpsyt.2023.1307473

Ejemplares similares

Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review
por: Nibbio, Gabriele, et al.
Publicado: (2022)

Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders
por: Barlati, Stefano, et al.
Publicado: (2020)

Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review
por: Deste, Giacomo, et al.
Publicado: (2023)

Schizophrenia during the COVID-19 pandemic
por: Barlati, Stefano, et al.
Publicado: (2021)

Are clinical severity and real-world functioning associated to committing crimes in people with severe mental illness? Results from a cross-sectional study on three cohorts of forensic and non-forensic patients
por: Calzavara Pinton, I., et al.
Publicado: (2023)

Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting
por: Barlati, Stefano, et al.
Publicado: (2022)

The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services
por: Vita, Antonio, et al.
Publicado: (2019)

Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics
por: Barlati, Stefano, et al.
Publicado: (2022)

Case report: application of pharmacogenetics in the personalized treatment of an elderly patient with a major depressive episode
por: Pjevac, Milica, et al.
Publicado: (2023)

Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
por: Vita, Antonio, et al.
Publicado: (2019)

Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Vita, Antonio, et al.
Publicado: (2023)

Efficacy of Functional Remediation on Cognitive and Psychosocial Functioning in Patients with Bipolar Disorder: Study Protocol for a Randomized Controlled Study
por: Accardo, Vivian, et al.
Publicado: (2023)

Psychiatric rehabilitation patterns in Italy: Results from the Italian Society of Psychosocial Rehabilitation (SIRP) survey
por: Viganò, Caterina, et al.
Publicado: (2023)

Patterns of Care for Adolescent With Schizophrenia: A Delphi-Based Consensus Study
por: Vita, Antonio, et al.
Publicado: (2022)

Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials
por: Vita, Antonio, et al.
Publicado: (2021)

Editorial: Case reports in schizophrenia and psychotic disorders
por: Tusconi, Massimo, et al.
Publicado: (2023)

Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report
por: Deste, Giacomo, et al.
Publicado: (2019)

Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia
por: Deste, Giacomo, et al.
Publicado: (2020)

Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting
por: Nibbio, Gabriele, et al.
Publicado: (2020)

Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
por: Minelli, Alessandra, et al.
Publicado: (2021)

Effectiveness of cognitive remediation in schizophrenia: What works and what does not work?
por: Vita, A., et al.
Publicado: (2021)

Brain Structural Effects of Antidepressant Treatment in Major Depression
por: Dusi, Nicola, et al.
Publicado: (2015)

European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022)

The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers
por: Minelli, Alessandra, et al.
Publicado: (2022)

Clinical Phenotypes Characterization in Pharmacogenetics Testing Trials for Major Depressive Disorder Treatment
por: Minelli, A.
Publicado: (2022)

Distance Learning Effects Among Italian Children and Parents During COVID-19 Related School Lockdown
por: Crisci, Giulia, et al.
Publicado: (2021)

Current Evidence and Theories in Understanding the Relationship between Cognition and Depression in Childhood and Adolescence: A Narrative Review
por: Barlati, Stefano, et al.
Publicado: (2022)

Editorial: Precision psychiatry from a pharmacogenetics perspective
por: Brown, Lisa C., et al.
Publicado: (2023)

Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020)

Blues in the Brain and Beyond: Molecular Bases of Major Depressive Disorder and Relative Pharmacological and Non-Pharmacological Treatments
por: Maffioletti, Elisabetta, et al.
Publicado: (2020)

Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders
por: Burns, Jamie A., et al.
Publicado: (2019)

The impact of the Covid-19 pandemic on patients with schizophrenia
por: Vita, Antonio, et al.
Publicado: (2022)

New Copy Number Variations in Schizophrenia
por: Magri, Chiara, et al.
Publicado: (2010)

The pharmacogenetics of the new-generation antipsychotics – A scoping review focused on patients with severe psychiatric disorders
por: Vasiliu, Octavian
Publicado: (2023)

Topical Pharmacotherapy for Actinic Keratoses in Older Adults
por: Calzavara-Pinton, Piergiacomo, et al.
Publicado: (2022)

The elephant in the room: the stressful psychological effects of COVID-19 pandemic in mental healthcare workers
por: Minelli, A., et al.
Publicado: (2022)

Family functioning and personal growth in Italian caregivers living with a family member affected by schizophrenia: Results of an add-on study of the Italian network for research on psychoses
por: Roncone, Rita, et al.
Publicado: (2023)

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder
por: Milanesi, Elena, et al.
Publicado: (2012)

Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype
por: Marcos-Vadillo, Elena, et al.
Publicado: (2022)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5kgdf63oadat0e6tfrlq5qm7t7